关注
May Wenche Jøraholmen
标题
引用次数
引用次数
年份
Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections
MW Jøraholmen, N Škalko-Basnet, G Acharya, P Basnet
European journal of pharmaceutical sciences 79, 112-121, 2015
1282015
Chitosan-coated liposomes for topical vaginal therapy: Assuring localized drug effect
MW Jøraholmen, Ž Vanić, I Tho, N Škalko-Basnet
International journal of pharmaceutics 472 (1-2), 94-101, 2014
1112014
PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha
MW Jøraholmen, P Basnet, G Acharya, N Škalko-Basnet
European Journal of Pharmaceutics and Biopharmaceutics 113, 132-139, 2017
892017
Localized therapy of vaginal infections and inflammation: Liposomes-in-hydrogel delivery system for polyphenols
MW Jøraholmen, P Basnet, MJ Tostrup, S Moueffaq, N Škalko-Basnet
Pharmaceutics 11 (2), 53, 2019
522019
The antimicrobial properties of chitosan can be tailored by formulation
MW Jøraholmen, A Bhargava, K Julin, M Johannessen, N Škalko-Basnet
Marine Drugs 18 (2), 96, 2020
372020
Liposomes-in-hydrogel delivery system enhances the potential of resveratrol in combating vaginal chlamydia infection
MW Jøraholmen, M Johannessen, K Gravningen, M Puolakkainen, ...
Pharmaceutics 12 (12), 1203, 2020
352020
Nanomedicines for the topical treatment of vulvovaginal infections: Addressing the challenges of antimicrobial resistance
Ž Vanić, MW Jøraholmen, N Škalko-Basnet
Advanced Drug Delivery Reviews 178, 113855, 2021
262021
The expanded role of chitosan in localized antimicrobial therapy
LM Hemmingsen, N Škalko-Basnet, MW Jøraholmen
Marine Drugs 19 (12), 697, 2021
242021
Altered Pseudomonas Strategies to Inhibit Surface Aspergillus Colonies
G Sass, H Nazik, P Chatterjee, P Shrestha, MC Groleau, E Déziel, ...
Frontiers in Cellular and Infection Microbiology 11, 734296, 2021
82021
Toxicity Assessment of Resveratrol Liposomes-in-Hydrogel Delivery System by EpiVaginalTM Tissue Model
MW Jøraholmen, P Damdimopoulou, G Acharya, N Škalko-Basnet
Pharmaceutics 14 (6), 1295, 2022
72022
A novel approach for the treatment of aerobic vaginitis: azithromycin liposomes-in-chitosan hydrogel
A Čačić, D Amidžić Klarić, S Keser, M Radiković, Z Rukavina, ...
Pharmaceutics 15 (5), 1356, 2023
52023
Advanced Drug Delivery Systems for Biologics
MW Jøraholmen, S Ternullo, AM Holsæter, GE Flaten, N Škalko‐Basnet
Fundamentals of Drug Delivery, 231-261, 2021
12021
Development of chitosan-coated liposomes for improved therapy of vaginal infections: clotrimazole as model drug
MWB Jøraholmen
Universitetet i Tromsø, 2012
12012
Texture characterization of chitosan-based liposomal hydrogels for dermal delivery of azithromycin
Z Rukavina, MW Jøraholmen, N Škalko-Basnet, D Božić, ...
EUFEPS Annual Meeting 2023, 127-127, 2023
2023
P 25 Vesicle-based resveratrol formulation for the topical treatment of Trichomonas vaginalis caused vaginal infection and inflammation
P Basnet, MW Jøraholmen, G Acharya, N Skalko-Basnet
Pregnancy Hypertension: An International Journal of Women's Cardiovascular …, 2017
2017
Surface modification of liposomes increases drug efficacy in local vaginal therapy
MW Jøraholmen
UiT The Arctic University of Norway, 2016
2016
Kan nanopartikulære formuleringer bedre behandlingen av genitale infeksjoner?
MW Jøraholmen, G Acharya, N Skalko-Basnet
2015
Pharmaceutical Sciences
MW Jøraholmen, N Škalko-Basnet, G Acharya, P Basnet
2015
Chitosan-coating as a mean to prolong vaginal residence time: Liposomes with clotrimazole
MW Jøraholmen, Ž Vanić, I Tho, N Škalko-Basnet
3rd Conference on „Innovation in Drug Delivery: Advances in Local Drug Deliv, 2013
2013
系统目前无法执行此操作,请稍后再试。
文章 1–19